We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.23B
AUM Growth
+$59.4M
Cap. Flow
+$16.2M
Cap. Flow %
1.31%
Top 10 Hldgs %
42.86%
Holding
211
New
11
Increased
78
Reduced
63
Closed
10

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.27M
2
PAYX icon
Paychex
PAYX
+$3.5M
3
SCHW
Charles Schwab
SCHW
+$2.97M
4
EPD icon
Enterprise Products Partners
EPD
+$2.65M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.36M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$3.22M
2
PNC icon
PNC Financial Services
PNC
+$2.38M
3
NEE icon
NextEra Energy
NEE
+$2.23M
4
VZ icon
Verizon
VZ
+$1.82M
5
STJ
St Jude Medical
STJ
+$1.53M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.24%
2 Healthcare 14.87%
3 Financials 10.21%
4 Technology 9.69%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
76
Gilead Sciences
GILD
$161B
$4.28M 0.35%
51,328
+1,406
+3% +$125K
COST icon
77
Costco
COST
$415B
$4.28M 0.35%
27,230
+1,830
+7% +$277K
UNH icon
78
UnitedHealth
UNH
$382B
$4.23M 0.34%
29,967
+2,517
+9% +$336K
SLB icon
79
SLB Ltd
SLB
$77.8B
$4.14M 0.34%
52,374
+4,134
+9% +$317K
TGT icon
80
Target
TGT
$62.1B
$4.04M 0.33%
57,800
+5,300
+10% +$395K
SO icon
81
Southern Company
SO
$110B
$3.97M 0.32%
74,050
-1,250
-2% -$62.9K
NKE icon
82
Nike
NKE
$61.9B
$3.9M 0.32%
70,710
+7,450
+12% +$424K
ADSK icon
83
Autodesk
ADSK
$44.3B
$3.74M 0.3%
69,100
+100
+0.1% +$5.79K
BA icon
84
Boeing
BA
$165B
$3.7M 0.3%
28,501
+500
+2% +$65.2K
PPL
85
PPL Corp
PPL
$27.3B
$3.69M 0.3%
97,720
+20,570
+27% +$783K
ITW icon
86
Illinois Tool Works
ITW
$81.4B
$3.66M 0.3%
35,150
-1,450
-4% -$152K
MET icon
87
MetLife
MET
$61B
$3.59M 0.29%
101,204
-1,683
-2% -$65.6K
IVZ icon
88
Invesco
IVZ
$13.3B
$3.55M 0.29%
139,100
+22,200
+19% +$659K
AAP icon
89
Advance Auto Parts
AAP
$3.37B
$3.35M 0.27%
20,700
+450
+2% +$69.5K
MPC icon
90
Marathon Petroleum
MPC
$90.3B
$3.3M 0.27%
86,970
+44,980
+107% +$1.65M
EPD icon
91
Enterprise Products Partners
EPD
$83.8B
$3.3M 0.27%
112,710
+98,810
+711% +$2.65M
PYPL icon
92
PayPal
PYPL
$49.5B
$3.28M 0.27%
89,800
+1,700
+2% +$65K
VLO icon
93
Valero Energy
VLO
$89.8B
$3.27M 0.27%
64,180
+400
+0.6% +$22.6K
TROW icon
94
T. Rowe Price
TROW
$25B
$3.14M 0.26%
43,080
+5,650
+15% +$421K
ZBH icon
95
Zimmer Biomet
ZBH
$17.7B
$3.03M 0.25%
25,935
-7,674
-23% -$868K
TJX icon
96
TJX Companies
TJX
$170B
$2.95M 0.24%
76,500
+1,200
+2% +$45.8K
FISV
97
Fiserv Inc
FISV
$27.2B
$2.89M 0.24%
53,180
-8,600
-14% -$443K
SWK icon
98
Stanley Black & Decker
SWK
$14.2B
$2.74M 0.22%
24,620
– –
TMO icon
99
Thermo Fisher Scientific
TMO
$211B
$2.73M 0.22%
18,510
-3,720
-17% -$549K
EMC
100
DELISTED
EMC CORPORATION
EMC
$2.69M 0.22%
99,200
– –
2 3
4
5 6

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cullinan Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Cullinan Associates held 211 positions worth $1.23B, up 5.1% from $1.17B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Cullinan Associates's Q2 2016 filing shows 11 new, 78 increased, 63 reduced and 10 closed positions. Its largest new stake was Charles Schwab: 104,400 shares worth $2.64M. The largest sale was Aflac, an estimated $3.22M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • Cullinan Associates's largest Q2 2016 buy was Charles Schwab: 104,400 shares worth $2.64M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q2 2016, an estimated $6.27M increase.
  • Cullinan Associates's biggest Q2 2016 reduction was Aflac, cutting an estimated $3.22M.
  • Cullinan Associates fully exited St Jude Medical in Q2 2016, selling an estimated $1.53M.
  • Cullinan Associates's ten largest holdings make up 43% of its $1.23B portfolio in Q2 2016.
  • Cullinan Associates opened 11 new positions and closed 10 in Q2 2016.
  • Cullinan Associates's portfolio value rose 5.1% quarter-over-quarter to $1.23B.

Based on Cullinan Associates's 13F filing for Q2 2016, filed 1 Jul 2016.